Net Income Summary of UniPharma Co., Ltd.

UniPharma Co., Ltd.'s latest annual net income in 2023 was -21.81 Million TWD , down -238.4% from previous year.
UniPharma Co., Ltd.'s latest quarterly net income in 2024 Q2 was -4.89 Million TWD , down 0.0% from previous quarter.
UniPharma Co., Ltd. reported an annual net income of -6.44 Million TWD in 2022, up 91.34% from previous year.
UniPharma Co., Ltd. reported an annual net income of -74.4 Million TWD in 2021, down -34.43% from previous year.
UniPharma Co., Ltd. reported a quarterly net income of -4.89 Million TWD for 2024 Q2, down 0.0% from previous quarter.
UniPharma Co., Ltd. reported a quarterly net income of -8.32 Million TWD for 2023 Q3, down -221.75% from previous quarter.

Annual Net Income Chart of UniPharma Co., Ltd. (2023 - 2019)

Name	Net Income	Net Income Difference
Allied Biotech Corporation	97.41 Million TWD	122.393%
GeneFerm Biotechnology Co., Ltd.	124.62 Million TWD	117.503%
Easywell Biomedicals, Inc.	-144.81 Million TWD	84.938%
TTY Biopharm Company Limited	1.12 Billion TWD	101.933%
Synmosa Biopharma Corporation	594.83 Million TWD	103.667%
Orient EuroPharma Co., Ltd.	143.94 Million TWD	115.154%
Center Laboratories, Inc.	-995.42 Million TWD	97.809%
Tien Liang BioTech Co., Ltd.	17.73 Million TWD	223.015%
Orient Pharma Co., Ltd.	22.28 Million TWD	197.869%
InnoPharmax Inc.	-70.83 Million TWD	69.204%
Johnson Chemical Pharmaceutical Works Co., Ltd.	79.7 Million TWD	127.369%
Excelsior Biopharma Inc.	-91.01 Million TWD	76.033%
DV Biomed Co., Ltd.	162.91 Million TWD	113.39%
Foresee Pharmaceuticals Co., Ltd.	-1.03 Billion TWD	97.895%
Handa Pharmaceuticals, Inc.	726.88 Million TWD	103.001%
Anxo Pharmaceutical Co., Ltd.	21.86 Million TWD	199.78%
Alar Pharmaceuticals Inc.	382.61 Million TWD	105.701%
Winston Medical Supply Co., Ltd.	158.75 Million TWD	113.74%
Mercury Biopharmaceutical Corporation	-43.81 Million TWD	50.217%
Bioray Biotech Co., Ltd	-11.55 Million TWD	-88.71%
TSH Biopharm Corporation Limited	61.98 Million TWD	135.189%